CHICAGO–(BUSINESS WIRE)–Oct. 22, 2016–
Masimo (NASDAQ:
MASI) announced today the findings of an abstract presented at the
American Society of Anesthesiologists’ (ASA) Annual Meeting in Chicago.
In the study, researchers at Hôpital Dupuytren, part of the Centre
Hospitalier Universitaire of Limoges, France (CHU Limoges), investigated
the clinical utility of noninvasive, continuous hemoglobin (SpHb®)
and PVI® (a measure of the dynamic changes in perfusion index
that occur during the respiratory cycle), two Masimo rainbow SET™
measurements. The researchers’ goal was to determine, at the scale of a
whole hospital, improvemen…

Más información: Study Investigates the Impact of Masimo Continuous SpHb® and PVI® on Anesthesia-Related Mortality